Company Bacterin International Holdings Inc Nyse

Equities

BONE

US05644R1014

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Medical Devices & Implants

Inactive Instrument

End-of-day quote Nyse Other stock markets
- ^USD	-

15/05	Earnings Flash (XTNT) XTANT MEDICAL HOLDINGS Reports Q1 Revenue $27.9M, vs. Street Est of $25.8M	MT
15/05	Transcript : Xtant Medical Holdings, Inc., Q1 2024 Earnings Call, May 15, 2024

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.

USD in Million	2022	Weight	2023	Weight	Delta
Orthobiologics 64.2 %	47	81.3 %	59	64.2 %	+24.31%
Spinal Implant 35.8 %	11	18.7 %	33	35.8 %	+202.34%

USD in Million	2022	Weight	2023	Weight	Delta
United States 94.0 %	57	98.6 %	86	94.0 %	+50.21%
Rest of World 6.0 %	1	1.4 %	5	6.0 %	+574.23%

Managers	Title	Age	Since
Sean Browne CEO	Chief Executive Officer	58	07/19/07
Scott Neils DFI	Director of Finance/CFO	40	01/19/01
Mark Schallenberger COO	Chief Operating Officer	-	16/23/16
Kevin Brandt PRN	Corporate Officer/Principal	59	09/18/09
Stephen C. Smith LAW	General Counsel	-	01/14/01

Members of the board	Title	Age	Since
Lori Mitchell-Keller BRD	Director/Board Member	58	16/23/16
John Bakewell BRD	Director/Board Member	62	01/18/01
Robert McNamara BRD	Director/Board Member	67	01/18/01
Sean Browne CEO	Chief Executive Officer	58	07/19/07
Jonn Beeson BRD	Director/Board Member	55	01/23/01
Stavros Vizirgianakis CHM	Chairman	53	23/22/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	130,216,541	119,413,642 ( 91.70 %)	0	91.70 %

Name	Equities	%	Valuation
OrbiMed Advisors Private Equity 56.15 %	73,114,592	56.15 %	66 M $
Altium Capital Management LP 5.873 %	7,647,873	5.873 %	7 M $
Stavros Vizirgianakis 4.771 %	6,213,125	4.771 %	6 M $
Nantahala Capital Management LLC 3.072 %	4,000,000	3.072 %	4 M $
Sean Browne 1.772 %	2,306,990	1.772 %	2 M $
Vanguard Group, Inc. (Subfiler) 1.189 %	1,548,312	1.189 %	1 M $
Jonn Beeson 0.9311 %	1,212,501	0.9311 %	1 M $
Kevin Brandt 0.7680 %	1,000,069	0.7680 %	901 062 $
Renaissance Technologies LLC 0.5862 %	763,310	0.5862 %	687 742 $
Scott Neils 0.5102 %	664,423	0.5102 %	598 645 $

Xtant Medical Holdings, Inc.

664 Cruiser Lane

59714, Belgrade

http://www.xtantmedical.com

address Bacterin International Holdings Inc(BONE)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+13.73%	13TCr
SMITH & NEPHEW PLC	-8.17%	1.1TCr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-4.33%	835.41Cr
GLAUKOS CORPORATION	+41.80%	567.43Cr
INSPIRE MEDICAL SYSTEMS, INC.	-21.94%	471.78Cr
AXONICS, INC.	+7.81%	342.28Cr
ENOVIS CORPORATION	-10.26%	275.74Cr
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-10.29%	210.67Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-13.58%	192.14Cr

Medical Devices & Implants